High Blood Pressure Drugs (Hypertension) Market Report

Global and Region High Blood Pressure Drugs (Hypertension) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：196
  • REPORT CODE：GMM914186
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of High Blood Pressure Drugs (Hypertension) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of High Blood Pressure Drugs (Hypertension)market, defines the market attractiveness level of High Blood Pressure Drugs (Hypertension) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of High Blood Pressure Drugs (Hypertension) industry, describes the types of High Blood Pressure Drugs (Hypertension) market, the applications of major players and the market size, and deeply analyzes the current situation of the global High Blood Pressure Drugs (Hypertension) market and the development prospects and opportunities of High Blood Pressure Drugs (Hypertension) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global High Blood Pressure Drugs (Hypertension) market in Chapter 13.

    By Player:

    • Novartis

    • Merck

    • Boryung

    • Pfizer

    • Bayer

    • Symplmed

    • Reata Pharmaceuticals

    • Eli Lilly

    • Takeda

    • Sanofi

    • Lung Biotechnology

    • Yuhan

    • Alvogen

    By Type:

    • ACEI

    • CCB

    • ARB

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 High Blood Pressure Drugs (Hypertension) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 High Blood Pressure Drugs (Hypertension) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 High Blood Pressure Drugs (Hypertension) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 High Blood Pressure Drugs (Hypertension) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise High Blood Pressure Drugs (Hypertension) Market Analysis and Outlook to 2022

    • 7.1 Global High Blood Pressure Drugs (Hypertension) Consumption (2017-2022)

    • 7.2 United States High Blood Pressure Drugs (Hypertension) Consumption (2017-2022)

    • 7.3 Europe High Blood Pressure Drugs (Hypertension) Consumption (2017-2022)

    • 7.4 China High Blood Pressure Drugs (Hypertension) Consumption (2017-2022)

    • 7.5 Japan High Blood Pressure Drugs (Hypertension) Consumption (2017-2022)

    • 7.6 India High Blood Pressure Drugs (Hypertension) Consumption (2017-2022)

    • 7.7 South Korea High Blood Pressure Drugs (Hypertension) Consumption (2017-2022)

    8 Region and Country-wise High Blood Pressure Drugs (Hypertension) Market Analysis and Outlook to 2028

    • 8.1 Global High Blood Pressure Drugs (Hypertension) Consumption Forecast (2022-2028)

    • 8.2 United States High Blood Pressure Drugs (Hypertension) Consumption Forecast (2022-2028)

    • 8.3 Europe High Blood Pressure Drugs (Hypertension) Consumption Forecast (2022-2028)

    • 8.4 China High Blood Pressure Drugs (Hypertension) Consumption Forecast (2022-2028)

    • 8.5 Japan High Blood Pressure Drugs (Hypertension) Consumption Forecast (2022-2028)

    • 8.6 India High Blood Pressure Drugs (Hypertension) Consumption Forecast (2022-2028)

    • 8.7 South Korea High Blood Pressure Drugs (Hypertension) Consumption Forecast (2022-2028)

    9 Global High Blood Pressure Drugs (Hypertension) Market Outlook by Types and Applications to 2022

    • 9.1 Global High Blood Pressure Drugs (Hypertension) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global ACEI Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CCB Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global ARB Consumption and Growth Rate (2017-2022)

    • 9.2 Global High Blood Pressure Drugs (Hypertension) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    10 Global High Blood Pressure Drugs (Hypertension) Market Outlook by Types and Applications to 2028

    • 10.1 Global High Blood Pressure Drugs (Hypertension) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global ACEI Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CCB Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global ARB Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global High Blood Pressure Drugs (Hypertension) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    11 Global High Blood Pressure Drugs (Hypertension) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global High Blood Pressure Drugs (Hypertension) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global High Blood Pressure Drugs (Hypertension) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 High Blood Pressure Drugs (Hypertension) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global High Blood Pressure Drugs (Hypertension) Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.2 Merck

      • 14.2.1 Merck Company Details

      • 14.2.2 Merck High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.3 Boryung

      • 14.3.1 Boryung Company Details

      • 14.3.2 Boryung High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Boryung High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.5 Bayer

      • 14.5.1 Bayer Company Details

      • 14.5.2 Bayer High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bayer High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.6 Symplmed

      • 14.6.1 Symplmed Company Details

      • 14.6.2 Symplmed High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Symplmed High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.7 Reata Pharmaceuticals

      • 14.7.1 Reata Pharmaceuticals Company Details

      • 14.7.2 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.9 Takeda

      • 14.9.1 Takeda Company Details

      • 14.9.2 Takeda High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Takeda High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.10 Sanofi

      • 14.10.1 Sanofi Company Details

      • 14.10.2 Sanofi High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.11 Lung Biotechnology

      • 14.11.1 Lung Biotechnology Company Details

      • 14.11.2 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.12 Yuhan

      • 14.12.1 Yuhan Company Details

      • 14.12.2 Yuhan High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Yuhan High Blood Pressure Drugs (Hypertension) Product and Service

    • 14.13 Alvogen

      • 14.13.1 Alvogen Company Details

      • 14.13.2 Alvogen High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Alvogen High Blood Pressure Drugs (Hypertension) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of High Blood Pressure Drugs (Hypertension)

    • Figure High Blood Pressure Drugs (Hypertension) Picture

    • Table Global High Blood Pressure Drugs (Hypertension) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global High Blood Pressure Drugs (Hypertension) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global High Blood Pressure Drugs (Hypertension) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global High Blood Pressure Drugs (Hypertension) Consumption by Country (2017-2022)

    • Figure United States High Blood Pressure Drugs (Hypertension) Consumption and Growth Rate (2017-2022)

    • Table Europe High Blood Pressure Drugs (Hypertension) Consumption and Growth Rate (2017-2022)

    • Figure China High Blood Pressure Drugs (Hypertension) Consumption and Growth Rate (2017-2022)

    • Figure Japan High Blood Pressure Drugs (Hypertension) Consumption and Growth Rate (2017-2022)

    • Figure India High Blood Pressure Drugs (Hypertension) Consumption and Growth Rate (2017-2022)

    • Figure South Korea High Blood Pressure Drugs (Hypertension) Consumption and Growth Rate (2017-2022)

    • Figure Global High Blood Pressure Drugs (Hypertension) Consumption Forecast by Country (2022-2028)

    • Figure United States High Blood Pressure Drugs (Hypertension) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe High Blood Pressure Drugs (Hypertension) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China High Blood Pressure Drugs (Hypertension) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan High Blood Pressure Drugs (Hypertension) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India High Blood Pressure Drugs (Hypertension) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea High Blood Pressure Drugs (Hypertension) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ACEI Consumption and Growth Rate (2017-2022)

    • Figure Global CCB Consumption and Growth Rate (2017-2022)

    • Figure Global ARB Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global ACEI Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CCB Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ARB Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Table Global High Blood Pressure Drugs (Hypertension) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global High Blood Pressure Drugs (Hypertension) Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Boryung (Foundation Year, Company Profile and etc.)

    • Table Boryung High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boryung High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Symplmed (Foundation Year, Company Profile and etc.)

    • Table Symplmed High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Symplmed High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Reata Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Lung Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Yuhan (Foundation Year, Company Profile and etc.)

    • Table Yuhan High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yuhan High Blood Pressure Drugs (Hypertension) Product and Service

    • Table Alvogen (Foundation Year, Company Profile and etc.)

    • Table Alvogen High Blood Pressure Drugs (Hypertension) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alvogen High Blood Pressure Drugs (Hypertension) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US